Prognostic relevance of contrast extravasation in patients undergoing endovascular embolization of acute bleeding - Scorecard - MDSpire

Prognostic relevance of contrast extravasation in patients undergoing endovascular embolization of acute bleeding

  • By

  • Hans-Jonas Meyer

  • Simon Riegelbauer

  • Matthias Mehdorn

  • Hans-Michael Tautenhahn

  • Uwe Scheuermann

  • Silke Zimmermann

  • Sebastian Ebel

  • Timm Denecke

  • Manuel Florian Struck

  • September 6, 2025

  • 0 min

Share

Clinical Scorecard: Clinical Implications of Contrast Extravasation in Patients Undergoing Endovascular Embolization for Acute Hemorrhage

At a Glance

CategoryDetail
ConditionAcute hemorrhage requiring endovascular embolization
Key MechanismsContrast extravasation on CT and angiography as a surrogate marker of bleeding severity
Target PopulationPatients with acute bleeding undergoing transarterial embolization
Care SettingTertiary referral centers with specialized interventional radiology services

Key Highlights

  • Endovascular embolization is a highly effective, less invasive treatment for acute bleeding with >95% technical success.
  • Contrast-enhanced CT has ~95% sensitivity for detecting clinically relevant acute bleeding and is routinely used for localization and procedural planning.
  • Contrast extravasation volume on CT may serve as a prognostic imaging biomarker correlating with bleeding severity, hemostatic therapy needs, and massive transfusion.

Guideline-Based Recommendations

Diagnosis

  • Perform multi-slice contrast-enhanced CT within 24 hours prior to angiography to localize bleeding and assess contrast extravasation.
  • Use triphasic CT imaging (native, arterial, portal-venous phases) for comprehensive evaluation.
  • Define acute bleeding by clinical symptoms, hemoglobin drop ≥16.1 g/L within 24 hours, hemorrhagic shock signs, or uncontrolled bleeding on endoscopy.

Management

  • Indicate transarterial embolization (TAE) for acute arterial bleeding refractory to conservative, surgical, or endoscopic treatment or recurrent bleeding.
  • Select embolic agents based on vascular anatomy, hemodynamics, microcatheter stability, bleeding mechanism, and interventionalist experience.
  • Perform TAE by experienced interventional radiologists using transfemoral or transbrachial access and appropriate microcatheters.

Monitoring & Follow-up

  • Monitor clinical signs of shock, hemoglobin levels, coagulation parameters (aPTT, prothrombin time), and transfusion requirements.
  • Evaluate for massive transfusion needs defined as ≥10 units PRBC in 24 hours or ≥5 units in 4 hours.
  • Assess 30-day all-cause mortality as a primary endpoint for prognostic evaluation.

Risks

  • Recognize variable clinical outcomes despite high technical success of embolization.
  • Consider limitations of CT sensitivity in very low bleeding rates or venous bleeding sites.
  • Account for patient comorbidities including anticoagulant or antiplatelet medication use.

Patient & Prescribing Data

Patients undergoing TAE for acute hemorrhage with available contrast-enhanced CT imaging within 24 hours.

Contrast extravasation volume on CT may predict bleeding severity and guide hemostatic therapy and transfusion strategies.

Clinical Best Practices

  • Use multidisciplinary team decision-making incorporating clinical, endoscopic, CT, and angiographic findings for TAE indication.
  • Ensure CT imaging is performed with contrast and within 24 hours prior to angiography for optimal assessment.
  • Employ experienced interventional radiologists and tailor embolic materials to individual patient anatomy and bleeding characteristics.
  • Utilize contrast extravasation volumetry as a potential prognostic tool pending further validation.

References

Original Source(s)

Related Content